Company: AIP
Filing Date: 2025-12-11
Form Type: S-3
Source: 0001193125-25-316098
Chunk: 52

Company: Arteris, Inc.
Filing Date: 2025-12-11
Form: S-3
Chunk 52
---
 in net tangible book value per share attributable to new investors in this 
 offering                                                                            |     |     |  1.56 |   |     |   |       |
| As adjusted net tangible book value per share as of September 30, 2025 after this   
 offering                                                                            |     |     |       |   |     |   |  1.15 |
| Dilution per share to new investors purchasing shares in this offering              |     |     |       |   |     | $ | 18.46 |

The shares sold in this offering, if any, will be sold from time to time at various prices. An increase of $1.00 per share in the price at which the shares are sold from the assumed offering price of $19.61 per share shown in the table above, assuming all of our common stock in the aggregate amount of $75.0 million is sold at that price, would increase our as adjusted net tangible book value per share after the offering to $1.15 per share and would increase the dilution in net tangible book value per share to new investors to $19.46 per share, after deducting commissions and estimated aggregate offering expenses payable by us. A decrease of $1.00 per share in the price at which the shares are sold from the assumed offering price of $19.61 per share shown in the table above, assuming all of our common stock in the aggregate amount of $75.0 million is sold at that price, would decrease our as adjusted net tangible book value per share after the offering to $1.14 per share and would decrease the dilution in net tangible book value per share to new investors to $17.47 per share, after deducting commissions and estimated aggregate offering expenses payable by us. This information is supplied for illustrative purposes only. To the extent that outstanding options are exercised or outstanding RSUs vest, investors purchasing our common stock in this offering will experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders. The above discussion and table are based on 43,584,272 shares of our common stock outstanding as of September 30, 2025, and excludes:

| • |     | 1,818,539 shares